APIs pour la recherche et les impuretés
Sous-catégories appartenant à la catégorie "APIs pour la recherche et les impuretés"
- Acides Aminés et Dérivés(12.327 produits)
- Anthraquinones et Dérivés(402 produits)
- Dérivés du Benzimidazole et de l’Imidazole(10.416 produits)
- Dérivés des Benzodiazépines(332 produits)
- Glucides et Glycoconjugués(5.050 produits)
- Esters et Dérivés(42.244 produits)
- Acides Gras et Dérivés Lipidiques(32.390 produits)
- Flavonoïdes et Polyphénols(17.078 produits)
- Radicaux Libres et Agents Oxydants/Réducteurs(212 produits)
- Cétones et Dérivés(2.398 produits)
- Antibiotiques Naturels et Semi-Synthétiques(6.351 produits)
- Nitriles et Dérivés Cyano(3.068 produits)
- Nitrosamines et Dérivés(55 produits)
- Nucléosides et Nucléotides(3.462 produits)
- Phosphates et Phosphonates Organiques(1.198 produits)
- Sulfonates et Sulfates Organiques(10.425 produits)
- Composés Organométalliques(4.419 produits)
- Autres(6.284 produits)
- Peptides et Protéines(3.140 produits)
- Polymères et Dérivés(99 produits)
- Dérivés des Purines et Pyrimidines(8.920 produits)
- Dérivés de Quinazoline et de Quinoléine(65.834 produits)
- Quinones et Dérivés(24.349 produits)
- Sels et Dérivés d’API(80.917 produits)
- Stéroïdes et Dérivés(4.939 produits)
- Sulfamides et Dérivés(2.580 produits)
- Terpénoïdes et Dérivés(3.842 produits)
- Thiazolidinediones et Thiopyranes(2.753 produits)
- Composés β-Adrénergiques(229 produits)
58257 produits trouvés pour "APIs pour la recherche et les impuretés"
(S)-Rabeprazole sodium
CAS :(S)-Rabeprazole sodium is an anticancer drug that acts as a kinase inhibitor. It is an analog of Rabeprazole and has been shown to inhibit the growth of cancer cells in vitro and in vivo. (S)-Rabeprazole sodium inhibits the activity of kinases, which are enzymes that play a key role in cell signaling pathways. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. (S)-Rabeprazole sodium has been tested against various types of cancer, including Chinese hamster ovary cells and tumor xenografts in mice. It has also been shown to inhibit elastin degradation, which is important for preventing metastasis of cancer cells. (S)-Rabeprazole sodium may be a promising candidate for the development of new anticancer drugs that target specific kinases and proteins involved in cancer cell growth and survival.
Formule :C18H21N3O3S•NaDegré de pureté :Min. 95%Masse moléculaire :382.43 g/molRoflumilast Impurity A
CAS :Roflumilast impurity A is a metabolite of roflumilast. It is a drug product that is used as an analytical standard for the determination of roflumilast in HPLC analysis. Roflumilast impurity A is not natural and is synthetic. It has been shown to be a substrate for CYP1A2, CYP2C8, CYP2C9, and CYP3A4 enzymes. Studies have shown that it may be involved in the metabolism of roflumilast through hydroxylation and deamination.
Formule :C16H14Cl2N2O3Degré de pureté :Min. 95%Masse moléculaire :353.2 g/molRef: 3D-IR168438
Produit arrêtéN-Hydroxymethyl Sumatriptan
CAS :N-Hydroxymethyl Sumatriptan is an analytical standard and a research and development impurity. It is also used as an API impurity in drug product manufacturing. N-Hydroxymethyl Sumatriptan can be synthesized by reacting the parent drug with hydroxyl radicals, which is a process that yields no side products. N-Hydroxymethyl Sumatriptan can be found in the following pharmacopoeia: United States Pharmacopoeia (USP) 11>, European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP)13>, British Pharmacopoeia (BP), and Chinese Pharmacopiae (CPC).
Formule :C15H23N3O3SDegré de pureté :Min. 95%Masse moléculaire :325.43 g/molN-Nitroso dorzolamide
N-Nitroso dorzolamide is a chemical compound used as an intermediate in the synthesis of dorzolamide, a carbonic anhydrase inhibitor used in the treatment of glaucoma and ocular hypertension.
Formule :C10H15N3O5S3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :353.44 g/molDesfluoro ezetimibe
CAS :Desfluoro ezetimibe is a synthetic cholesterol-lowering drug that inhibits intestinal cholesterol absorption. It is chemically synthesized, and the process includes the introduction of fluorine at the 3-position of the C-ring. Desfluoro ezetimibe is not metabolized in humans, but it may be subject to oxidative degradation. The product is also subject to oxidation by light and air, which may result in formation of impurities. The drug substance has been validated as well as its isomers and efficiencies in mass spectrometry detection.
Formule :C24H22FNO3Degré de pureté :Min. 95%Couleur et forme :White To Off-White SolidMasse moléculaire :391.43 g/molRef: 3D-FD21193
Produit arrêtéIvermectin impurity I
CAS :Ivermectin impurity I is an analytical standard that is used for pharmacopoeia and custom synthesis. It is a natural metabolite of the drug Ivermectin, which has been shown to have anti-inflammatory properties in mice. Ivermectin impurity I binds to nicotinic acetylcholine receptors, leading to muscle paralysis and death. This compound is found in high purity for research and development purposes.
Formule :C48H74O14Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :875.09 g/molSimvastatin acid
CAS :Simvastatin acid is the active form of simvastatin, a drug used to lower blood cholesterol levels. Simvastatin acid inhibits HMG-CoA reductase, the enzyme that converts HMG-CoA to mevalonate. This conversion is a rate-limiting step in the synthesis of cholesterol and other lipids. Simvastatin acid binds to polymerase chain and drug transporter proteins, which leads to cell lysis. The concentration–time curve for simvastatin acid is linear and the half-life is approximately 12 hours. When simvastatin acid is administered with drugs that are potent inducers of CYP3A4 or UGT1A1 enzymes, there may be an increased risk for drug interactions. Simvastatin acid has shown no significant human pharmacokinetic interactions with food or grapefruit juice at doses up to 200 mg/day. There are limited data on the pharmacokinetics of simvastatin
Formule :C25H40O6Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :436.58 g/molRocuronium Bromide EP Impurity F Bromide
CAS :Rocuronium Bromide EP Impurity F Bromide is an impurity found in Rocuronium Bromide EP. It is a natural component of the drug product, which is a synthetic drug. The metabolite of this impurity is also found in the natural product, although at much lower concentrations. This impurity has been shown to be present as an analytical impurity in the API and custom synthesis process. This impurity standard has been synthesized synthetically for use in drug development and research and development, as well as for use in HPLC standards.Formule :C34H55N2O4·BrDegré de pureté :Min. 95%Masse moléculaire :635.72 g/molRef: 3D-IR178405
Produit arrêté(4-Chlorophenyl)diphenylmethanol
CAS :Please enquire for more information about (4-Chlorophenyl)diphenylmethanol including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formule :C19H15ClODegré de pureté :Min. 95%Masse moléculaire :294.8 g/molCiprofloxacin ep impurity C
CAS :Ciprofloxacin ep impurity C is a synthetic compound. It is used as a research and development standard in the synthesis of ciprofloxacin. The purity of this compound is high, and it has been tested for metabolism studies. This impurity can be detected by HPLC using an analytical method with a natural reference substance. This impurity has not been evaluated for pharmacopoeia or CAS number.
Formule :C15H16FN3O3Degré de pureté :Min. 95%Masse moléculaire :305.30 g/molChlorthalidone impurity E
CAS :Chlorthalidone impurity E is an analytical standard for the HPLC analysis of chlorthalidone in pharmaceutical drug products and is a metabolite of chlorthalidone. Chlorthalidone impurity E is an API impurity that can be found in the synthesis of chlorthalidone, and it has been detected as a minor component in certain drug products. It is important to have an accurate specification for this compound, since it can affect the pharmacological properties of the drug product. The purity level of this compound must be at least 98% or greater to ensure that there are no contaminants present. This compound is also a metabolite of chlorthalidone and is used as a pharmacopoeia reference substance for testing equipment calibration.END>
Formule :C14H11ClN2O3SDegré de pureté :Min. 95%Masse moléculaire :322.77 g/molD-6-Cyano-6-norlysergic acid methyl ester
CAS :Please enquire for more information about D-6-Cyano-6-norlysergic acid methyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formule :C17H15N3O2Degré de pureté :Min. 95%Masse moléculaire :293.32 g/molTriethylene glycol flufenamate
CAS :Etofenamate impurity
Formule :C20H22F3NO5Degré de pureté :Min. 95%Couleur et forme :Clear LiquidMasse moléculaire :413.39 g/molAtorvastatin calcium trihydrate EP Impurity G
CAS :Atorvastatin is a drug that belongs to the class of statins. It is used for the treatment of high cholesterol levels and other related diseases, such as cardiovascular disease. Atorvastatin calcium trihydrate EP Impurity G is an impurity that may be present in atorvastatin calcium trihydrate. This compound has not been found to have any pharmacological activity.
Formule :C34H37FN2O5Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :572.67 g/molRef: 3D-IA182820
Produit arrêtéGS 441524 triphosphate
CAS :Triphosphorylated form of an antiviral nucleoside analog with activity against zoonotic feline infectious peritonitis virus (FIPV) and severe acute respiratory syndrome (SARS) virus from Coronaviridae family. The compound is the biologically active form of the GS 441524 prodrug and being triphosphorylated, it competes with natural nucleoside triphosphates in cells and interferes with viral RNA synthesis. Made to order.
Formule :C12H12N5O13P3·4NaDegré de pureté :(31P-Nmr) Min. 95 Area-%Couleur et forme :White PowderMasse moléculaire :531.20 g/mol
